Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03410368
What this trial is testing

NK Cell-based Immunotherapy as Maintenance Therapy for Small-Cell Lung Cancer.

Who this might be right for
Small Cell Lung Cancer
jiuwei cui 120
Not applicableUnknownNCT05115279
What this trial is testing

Outcomes of Breast Conservative Surgery for Post Chemotherapy Tumour Size After Response to Neoadjuvant Chemotherapy

Who this might be right for
Safety of Excision the New Tumor Size
Assiut University 1
Not applicableUnknownNCT05141279
What this trial is testing

Accuracy Of Contrast Enhanced Mamography in Predicting Response of Breast Cancer Post Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
Assiut University 50
Testing effectiveness (Phase 2)Study completedNCT01137968
What this trial is testing

Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Geron Corporation 116
Not applicableUnknownNCT04110769
What this trial is testing

Development of Biomarker for the Evaluation of Response After Neoadjuvant Therapy in Patients With Pancreatic Cancer

Who this might be right for
Genetic ChangeChemotherapy EffectPancreatic Cancer
Asan Medical Center 10
Testing effectiveness (Phase 2)UnknownNCT02976142
What this trial is testing

The Efficacy of Surgical Treatment After Neoadjuvant Chemotherapy Plus Intraperitoneal Immunotherapy Versus Chemotherapy Alone for Patients With Positive Wash Cytology Gastric Cancer

Who this might be right for
Gastric Cancer, Metastatic
Moscow Clinical Scientific Center 150
Testing effectiveness (Phase 2)Study completedNCT00742027
What this trial is testing

Phase II Study of Oral Panobinostat in Adult Participants With Relapsed/Refractory Classical Hodgkin's Lymphoma

Who this might be right for
Classical Hodgkin's Lymphoma
Novartis Pharmaceuticals 129
Testing effectiveness (Phase 2)Study completedNCT00318370
What this trial is testing

Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Neoplasms
Morphotek 58
Not applicableStudy completedNCT04813627
What this trial is testing

Epidemiological Study to Monitor Study Participants With Resected Stage II (High Risk) or Stage III Colorectal Cancer for Circulating Tumor DNA Before, During and After Their Treatment With Adjuvant Chemotherapy

Who this might be right for
Colorectal Cancer Stage IIColorectal Cancer Stage III
BioNTech SE 2,079
Testing effectiveness (Phase 2)Study completedNCT00791141
What this trial is testing

Adjuvant Cetuximab and Chemoradiation in Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Heinrich-Heine University, Duesseldorf 80
Testing effectiveness (Phase 2)Looking for participantsNCT07296705
What this trial is testing

Neoadjuvant Zanidatamab + Tislelizumab + Chemotherapy for Selective Bladder Preservation in HER2-Positive MIBC

Who this might be right for
Muscle Invasive Bladder Cancer (MIBC)
Fujian Medical University Union Hospital 25
Not applicableStudy completedNCT05888129
What this trial is testing

Clinical Outcomes of Surgery After Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer

Who this might be right for
Postoperative Complications
Asan Medical Center 1
Early research (Phase 1)Ended earlyNCT02018523
What this trial is testing

Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Jun Zhang 7
Testing effectiveness (Phase 2)Looking for participantsNCT07593976
What this trial is testing

Evaluation of [68Ga]Ga-NOTA-anti-HER2-sdAb PET/CT for Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in HER2 Positive Early Breast Cancer

Who this might be right for
Breast Cancer
Centre Henri Becquerel 42
Large-scale testing (Phase 3)Study completedNCT07113574
What this trial is testing

Pharmacokinetics of Meropenem and Aztreonam After Intraperitoneal Administration Via Cycler-therapy in APD Patients Without Peritonitis

Who this might be right for
Peritoneal Dialysis Associated PeritonitisPeritoneal Dialysis (PD)Peritoneal Dialysis+8 more
Karl Landsteiner Insitute for Nephrology and Haemato-Oncology 12
Testing effectiveness (Phase 2)Ended earlyNCT04856176
What this trial is testing

Sargramostim Plus Pembrolizumab with or Without Pemetrexed in Patients with Advance Non-small Cell Lung Cancer After Completion of Chemoimmunotherapy

Who this might be right for
Advanced Lung Non-Small Cell CarcinomaNon-Small Cell Carcinoma of Lung, TNM Stage 4
Tufts Medical Center 5
Testing effectiveness (Phase 2)Study completedNCT02705820
What this trial is testing

Switch Maintenance Pembrolizumab in Patients With NSCLC After First Line Platinum Doublet Chemotherapy

Who this might be right for
Metastatic Non Small Cell Lung Cancer
Bank of Cyprus Oncology Centre 48
Not applicableUnknownNCT05146050
What this trial is testing

Olfactory Change After Chemo-radiotherapy for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 107
Large-scale testing (Phase 3)UnknownNCT03398291
What this trial is testing

Simultaneous Resection of Pancreatic Cancer and Liver Oligometastasis After Induction Chemotherapy

Who this might be right for
Pancreatic CancerLiver MetastasesSurgery
Fudan University 300
Not applicableStudy completedNCT00168168
What this trial is testing

ACB A Randomized Study of 2.5ug/kg/Day vs. 5ug/kg/Day Dose of G-CSF After High Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell/Marrow Transplant Recipients FILE#17159

Who this might be right for
Peripheral Stem Cell/Marrow Transplant
Alberta Health services 60
Next Page